Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GIST - Gastrointestinal Stromal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00457743
What this trial is testing

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Pfizer 36
Early research (Phase 1)Ended earlyNCT00573404
What this trial is testing

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Study completedNCT01151852
What this trial is testing

Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 81
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Post-approval studies (Phase 4)Study completedNCT04825574
What this trial is testing

Study for Patients Previously Treated in Avapritinib Clinical Trials

Who this might be right for
Gastrointestinal Stromal Tumors
Blueprint Medicines Corporation 2
Early research (Phase 1)WithdrawnNCT02268435
What this trial is testing

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center
Not applicableLooking for participantsNCT03716089
What this trial is testing

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site

Who this might be right for
GIST of StomachGastric CancerSurgery+1 more
Fujian Medical University 250
Testing effectiveness (Phase 2)Study completedNCT00005874
What this trial is testing

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcomaSmall Intestine Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT02877368
What this trial is testing

Sarcopenia in Patients With Gastrointestinal Stromal Tumours

Who this might be right for
Gastrointestinal Stromal Tumours
CHU de Reims 31
Not applicableStudy completedNCT04599660
What this trial is testing

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

Who this might be right for
GIST
Italian Sarcoma Group 700
Early research (Phase 1)Study completedNCT02071862
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Who this might be right for
Solid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more
Calithera Biosciences, Inc 210
Testing effectiveness (Phase 2)Study completedNCT02257541
What this trial is testing

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Advanced Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT01289028
What this trial is testing

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 125
Early research (Phase 1)Study completedNCT04530981
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, LLC 13
Not applicableNot Yet RecruitingNCT07273045
What this trial is testing

A Comprehensive, Multinational GIST Registry

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)GIST - Gastrointestinal Stromal Tumor
Universität Duisburg-Essen 1,000
Large-scale testing (Phase 3)UnknownNCT00685828
What this trial is testing

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 946
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Large-scale testing (Phase 3)Study completedNCT00041197
What this trial is testing

Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 732
Next Page